DRKS00010937已完成不适用
A Fecal marker of Intestinal inflammation for RElapse prediction in routine monitoring of Crohn's disease patients (FIRE) - FIRE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 525
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Participating Crohn's disease patients are required to meet all of the following criteria:
- •with status post moderate / severe disease flare which required treatment with steroids, immunosuppressives (Thiopurine,Methotrexat), and / or anti-TNF; currently in clinical remission (HBI < 5) for at least 1 month under therapy with immunosuppressives and / or TNF antibodies; ileocecal and / or colonic disease, with or without involvement of proximal (small bowel, gastroduodenal) GI areas.
排除标准
- •active disease (HBI = 5); current treatment of CD with corticosteroids; disease patterns restricted to proximal (small bowel, gastroduodenal) GI areas; pregnancy.
研究者
相似试验
尚未招募
不适用
Detection of FIT- , fecal- and mucosa associated microbiome and microRNA in patients with suspected colorectal adenomas or cancerMicrobiome, MicroRNA, Colorectal cancer, AdenomasNL-OMON27020Erasmus Medical Center160
已完成
不适用
Research for biomarkers of inflammatory bowel disease. - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab treatmentsJPRN-UMIN000019958Iwate Medical University Kochi Medical School Hospital Keio University School of Medicine80
已完成
不适用
Identification of new biomarkers for intestinal barrier functioHealthy adultsJPRN-UMIN000039148Meiji Co., Ltd.112
已完成
不适用
Analysis of intestinal flora by T-RFLPHealthyJPRN-UMIN000004123St. Luke's International Hospital100
已完成
不适用
Detection of FIT- , fecal- and mucosa- associated microbiome and microRNA in patients with suspected colorectal adenomas or cancerColorectal cancerNL-OMON48887Erasmus MC, Universitair Medisch Centrum Rotterdam160